Pharmaceuticals - List of Manufacturers, Suppliers, Companies and Products

Pharmaceuticals Product List

1～9 item / All 9 items

Displayed results
[Seminar] The Current Status of Biopharmaceuticals Including Vaccines in Our Country

[Seminar] The Current Status of Biopharmaceuticals Including Vaccines in Our Country

Know-how for acquiring subsidies for the establishment of domestic development and manufacturing bases.

Our company will hold a seminar titled "Current Status of Biopharmaceuticals Including Vaccines in Our Country." In light of the spread of the novel coronavirus, the establishment of development and manufacturing bases for biopharmaceuticals, including vaccines, in Japan has been recognized by the government as an urgent issue from the perspective of not only public health but also risk management for national security. Therefore, this seminar will provide detailed explanations on global market trends for vaccines and biopharmaceuticals, policies related to the establishment of biopharmaceutical bases in our country, and know-how for acquiring subsidies that companies can utilize when participating in the establishment of these bases. [Seminar Details] ■ Date and Time: May 30 (Thursday) 13:30 - 15:30 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Instructors: Mizuho Research & Technologies Co., Ltd. Social Policy Consulting Department, Social Resilience Promotion Team Chief Consultant: Eri Nichiro Consultant: Yuki Sato *For more details, please refer to the PDF document or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Seminar] Ministry of Health, Labour and Welfare: Future Prospects of the Generic Pharmaceutical Industry

[Seminar] Ministry of Health, Labour and Welfare: Future Prospects of the Generic Pharmaceutical Industry

Discussion content in the "Study Group on the Structure of Industry for Achieving Stable Supply of Generic Pharmaceuticals, etc."

Our company will hold a seminar titled "Ministry of Health, Labour and Welfare: Future Prospects of the Generic Pharmaceutical Industry." Generic pharmaceuticals account for over 50% of the total quantity of prescription drugs and contribute to the improvement of healthcare financing, playing an essential role as social infrastructure. On the other hand, in response to the supply shortage of generic pharmaceuticals triggered by regulatory actions against certain generic pharmaceutical companies, a study group titled "Study on the Structure of the Industry for Achieving Stable Supply of Generic Pharmaceuticals" was established in July 2023 to engage in broad discussions on the ideal state of the generic pharmaceutical industry and the industrial policies needed to realize it. This seminar will provide detailed explanations not only of the discussions from this study group but also of the future prospects of the generic pharmaceutical industry. 【Seminar Details】 ■ Date and Time: June 13 (Thursday) 13:30 - 15:30 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Speaker: Ministry of Health, Labour and Welfare Member of the "Study on the Structure of the Industry for Achieving Stable Supply of Generic Pharmaceuticals" Director of the Healthcare Division, Corporate Finance Department 6, Development Bank of Japan Mr. Masafumi Nozawa *For more details, please refer to the PDF document or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Overview of Pharmaceutical GDP/GMP Operations Fujilogistic Holdings

Overview of Pharmaceutical GDP/GMP Operations Fujilogistic Holdings

Confident in our know-how: We can provide services tailored to our customers' needs under various business licenses!

This document introduces an overview of the operation of pharmaceutical GDP/GMP. It includes various content such as "business licenses," "examples of medical pharmaceutical supply chains," operational and transportation flows, and case studies from manufacturing and sales, accompanied by photos and tables. The content is designed to be easily referenced when considering implementation. Please feel free to download and take a look. 【Contents (partial)】 ■ Business Licenses ■ Examples of Medical Pharmaceutical Supply Chains ■ Examples of Veterinary Pharmaceutical Supply Chains ■ Life Sciences ■ Case Studies *For more details, please refer to the PDF document or feel free to contact us.

  • Analysis and prediction system

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
What strategies should be implemented in response to changes in customer behavior during the COVID-19 pandemic?

What strategies should be implemented in response to changes in customer behavior during the COVID-19 pandemic?

Explaining examples that provide hints for developing marketing strategies in response to customer behavior during the COVID-19 pandemic!

Several months have passed since the state of emergency was declared due to the spread of the novel coronavirus, yet the end is still not in sight. As the second and third waves hit, companies are facing a pressing situation where they can no longer afford to stall their business activities. Here, we will consider customer behavior during the pandemic and think of examples that can serve as hints for developing marketing strategies in response. *For detailed content of the column, please refer to the related link. For more information, feel free to contact us.*

  • SFA (Sales Support System)
  • Online business negotiation system
  • Ad management and operations

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global Marine-Derived Pharmaceuticals Market Research Report (to 2027)

Global Marine-Derived Pharmaceuticals Market Research Report (to 2027)

World Market for Marine-Derived Pharmaceuticals (up to 2027): Ethers, Peptides, Phenols, Steroids

According to a report by 360iResearch, the global market size for marine-derived pharmaceuticals, which was $10.54 billion in 2021, is expected to reach $11.46 billion in 2022 and further expand at an average annual rate of 8.90% to reach $17.58 billion by 2027. This document is a market research report summarizing a multifaceted investigation into the global market for marine-derived pharmaceuticals, including an introduction, research methodology, executive summary, market overview, market insights, analysis by type (ethers, peptides, phenols, steroids), analysis by raw material (algae, invertebrates, microorganisms), analysis by delivery method (antihypertensives, anti-inflammatory drugs, antibiotics, antitumor drugs, antiviral drugs), regional analysis (North and South America, United States, Canada, Brazil, Asia-Pacific, Japan, China, India, South Korea, Taiwan, Europe/Middle East/Africa, United Kingdom, Germany, France, Russia, and others), competitive landscape, and company information.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.